Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Both NXNL1 and NXNL2 are important for photoreceptor survival in the mouse
Author Affiliations & Notes
  • Zheng LI
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Imen Harichane
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Ying Yang
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Emmanuelle Clerin
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Jose Alain Sahel
    UPMC, Pittsburgh, Pennsylvania, United States
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Isabelle S Audo
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Christina Zeitz
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Thierry Leveillard
    Sorbonne Université, Inserm, CNRS, Institut de la Vision, IDV, Paris, France
  • Footnotes
    Commercial Relationships   Zheng LI None; Imen Harichane None; Ying Yang None; Emmanuelle Clerin Patent of RdCVF2, Code P (Patent); Jose Sahel Avista Therapeutics, Tenpoint, Code C (Consultant/Contractor), Clinical Trials: Gensight, SparingVision, Meira, Code F (Financial Support), Gensight, Sparing Vision, Avista, Tenpoint, Prophesee, Chronolife, Tilak Healthcare, SharpEye, Cilensee, Vegavect, Code O (Owner), Allotopic Expression, Rod-derived Cone Viability Factor and related patents, Code P (Patent), Patent Royalties, Gensight, Code R (Recipient), Observer : Gensight, SparingVision, Avista, Vegavect. President : Fondation Voir et Entendre, Paris ; President : StreetLab, Paris., Code S (non-remunerative); Isabelle Audo None; Christina Zeitz None; Thierry Leveillard Rod-derived Cone Viability Factor and related patents, Code P (Patent)
  • Footnotes
    Support  This project is funded by Sorbonne University and China Scholarship Council (CSC).
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4771. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zheng LI, Imen Harichane, Ying Yang, Emmanuelle Clerin, Jose Alain Sahel, Isabelle S Audo, Christina Zeitz, Thierry Leveillard; Both NXNL1 and NXNL2 are important for photoreceptor survival in the mouse. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4771.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinitis pigmentosa (RP) is characterized by progressive rod then cone degeneration, leading to blindness in severe cases with no therapeutic option. The nucleoredoxin-like 1 (NXNL1) gene codes for two alternative splice isoforms: a short form, rod-derived cone viability factor (RdCVF), promoting cone aerobic glycolysis and a long form (RdCVFL) modulating oxidative damage. A phase I/II trial (NCT05748873) of gene therapy with both isoforms in RP is ongoing. NXNL2, a paralogue of NXNL1, also encodes two isoforms with cone-protective function. We investigated whether both NXNL1 and NXNL2 products are required for photoreceptor survival in mouse retina. We also studied the benefit of combined both short forms in photoreceptor protection by using the rd10 mouse model of RP.

Methods : Double knockout Nxnl1-/-Nxnl2-/- mice were generated. Their retinal phenotype was investigated using electroretinogram (ERG) recording and optical coherence tomography (OCT) at different ages, compared to Nxnl1-/- or Nxnl2-/- and wild-type (wt) mice.
The effect of combined or separate overexpression of RdCVF and RdCVF2 was tested using AAV2/8 subretinal delivery in rd10 mice at PN14 compared with rd10 injected with AAV2/8-GFP. Visual function was evaluated by ERG recording and a quantitative optomotor response (qOMR) system 1 month post injection.

Results : Nxnl1-/-Nxnl2-/- mice showed severer rod dysfunction at age 3, 6, and 12 months compared to Nxnl1-/-, Nxnl2-/-, and wt mice. The overall average reduction of scotopic ERG response is Nxnl1-/-Nxnl2-/- 29.0%(n≥7), Nxnl1-/- 16.3% (n≥8), Nxnl2-/- 10.7% (n≥5), compared to wt (n=11) mice. In addition, the outer nuclear layer (ONL) thickness was reduced on OCT at all ages, the average reduction is Nxnl1-/-Nxnl2-/- 15.8% (n≥9), Nxnl1-/- 13.3% (n≥9), Nxnl2-/- 7.1%(n≥5), compared to wt (n≥11) mice.
Rd10 mice injected with a combination of AAV-RdCVF and AAV-RdCVF2 (n=3) showed increased visual acuity on the qOMR compared to controls injected with AAV-RdCVF (n=2), AAV-RdCVF2 (n=3), and AAV-GFP (n=3). Preliminary data revealed larger photopic ERG responses in rd10 mice injected with the combination compared to the other 3 groups.

Conclusions : Both Nxnl1 and Nxnl2 are essential for photoreceptor survival in mice. The combination of RdCVF and RdCVF2 promoted vision rescue in rd10 mice, showing clinical potential for RP. Further investigation will decipher the underlying mechanism of RdCVF2 in cone rescue.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×